Journal of Diabetes Mellitus
Vol.5 No.4(2015), Paper ID 60814, 9
pages
DOI:10.4236/jdm.2015.54032
Switching from Sitagliptin to Alogliptin under Treatment with Pioglitazone Increases High Molecular Weight Adiponectin in Type 2 Diabetes: A Prospective Observational Study
Akinori Tokito, Nobuyuki Koriyama, Ayako Ijuin, Kazuma Ogiso, Yoshihiko Nishio, Michihisa Jougasaki
Institute for Clinical Research, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
Department of Diabetes and Endocrine Medicine, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
Department of Diabetes and Endocrine Medicine, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
Department of Diabetes and Endocrine Medicine, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
Department of Diabetes and Endocrine Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan
Institute for Clinical Research, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
Copyright © 2015 Akinori Tokito, Nobuyuki Koriyama, Ayako Ijuin, Kazuma Ogiso, Yoshihiko Nishio, Michihisa Jougasaki et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Tokito, A. , Koriyama, N. , Ijuin, A. , Ogiso, K. , Nishio, Y. and Jougasaki, M. (2015) Switching from Sitagliptin to Alogliptin under Treatment with Pioglitazone Increases High Molecular Weight Adiponectin in Type 2 Diabetes: A Prospective Observational Study.
Journal of Diabetes Mellitus,
5, 258-266. doi:
10.4236/jdm.2015.54032.